Contact Information: CONTACT: Elio Evangelista (919) 433-0214
Key Opinion Leaders Average $25,000 to $50,000 in Annual Advising Fees
| Source: Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - January 24, 2008) - It pays to be an expert in a
medical field -- literally.
Top-tier key opinion leaders earn between $25,000 and $50,000 annually for
their consulting and advising services, according to a new study from
Cutting Edge Information (http://www.PharmaOpinionLeaders.com).
Key opinion leaders (KOLs) are well-respected physicians who have risen to
the top of their medical specialty. Pharmaceutical, biotechnology and
medical device companies use opinion leaders' services to develop new
clinical research strategies, to deliver promotional or education speeches
and to serve on advisory panels for their key product franchises. Cutting
Edge Information's study found that, on average, these high-profile opinion
leaders are recognized as experts in their field by their peers.
Top-tier opinion leaders receive the highest levels of annual funding,
according to the study. Tier 2 physicians, who are not as influential on a
global scale as Tier 1 doctors, receive between $10,000 and $25,000 annual
for consulting and advising fees. But pharmaceutical companies are quick
to point out that key opinion leaders' services are difficult to obtain
because KOLs work with multiple companies in a given year.
"It's important to note that many companies have annual spending limits in
place to curb excessive payments to one physician or another," said Elio
Evangelista, Research Team Leader at Cutting Edge Information. "Most of
the time, these limits are set around $10,000, which goes to show that key
opinion leaders have many ongoing advisory relationships."
"Pharmaceutical Opinion Leader Management," available at
http://www.PharmaOpinionLeaders.com, examines the structures, strategies
and resource allocations for the departments responsible for handling
thought leader relationships. The report also includes detailed data for
opinion leader recruitment and segmentation, as well as highlights new
trends and issues concerning compliance to government regulation.
"Thought Leader Compensation: Establishing Fair-Market Value Procedures" is
a study of 46 pharmaceutical, biotechnology and medical device companies'
thought leader management structures, resources, processes and activities.
The report includes detailed segmentation and funding data collected from
top companies, such as Pfizer, Bristol-Myers Squibb, Schering-Plough and
Novartis.
Download a free summary of "Pharmaceutical Opinion Leader Management:
Cultivating Today's Influential Physicians for Tomorrow" or purchase the
report at:
http://www.cuttingedgeinfo.com/pharmaopinionleaders/index.htm#body